CN Stock MarketDetailed Quotes

600079 Humanwell Healthcare

Watchlist
  • 23.81
  • +0.18+0.76%
Market Closed Dec 27 15:00 CST
38.86BMarket Cap19.87P/E (TTM)

Humanwell Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-15.92%3.84B
-12.90%3.55B
9.53%3.54B
-20.70%4.1B
13.36%4.57B
30.42%4.08B
-9.23%3.23B
0.21%5.18B
-9.25%4.03B
-24.29%3.13B
Transactional financial assets
1.83%918.86M
2.14%926.84M
1.41%925.16M
-1.04%935.93M
-4.65%902.31M
-3.26%907.39M
-1.01%912.32M
1.21%945.72M
72.56%946.3M
71.08%938.01M
Notes receivable and accounts receivable
9.37%9.82B
6.93%9.46B
9.12%9.38B
7.78%8.21B
9.25%8.98B
13.29%8.85B
14.01%8.6B
11.75%7.62B
11.44%8.22B
11.37%7.81B
-Notes receivable
46.93%80.44M
8.13%89.34M
-4.91%75.91M
7.41%96.08M
39.82%54.75M
72.85%82.63M
33.14%79.83M
51.39%89.44M
12.08%39.15M
14.82%47.8M
-Accounts receivable
9.13%9.74B
6.91%9.37B
9.26%9.31B
7.79%8.11B
9.10%8.93B
12.93%8.77B
13.86%8.52B
11.41%7.53B
11.43%8.18B
11.35%7.76B
Other receivables (including interest and dividends)
-21.68%405.47M
-15.55%454.22M
-1.50%502.83M
18.82%503.2M
-2.52%517.73M
3.55%537.86M
-67.58%510.5M
-29.30%423.51M
-49.75%531.12M
-50.84%519.44M
-Dividend receivable
----
----
----
----
--29.44M
----
----
----
----
-46.32%12.56M
-Accrued interest receivable
----
----
----
----
--8.83M
----
----
----
----
----
-Other receivable
----
-15.55%454.22M
----
----
--479.47M
6.11%537.86M
----
-26.09%423.51M
----
-50.94%506.88M
Advance payment
-27.86%545.48M
-18.43%618.39M
-0.01%786.33M
-14.38%721.24M
17.09%756.16M
13.21%758.11M
11.57%786.38M
18.27%842.41M
0.14%645.81M
-4.31%669.67M
Inventories
15.49%3.92B
14.76%3.88B
14.59%3.81B
5.80%3.62B
6.43%3.4B
4.36%3.38B
4.16%3.32B
9.40%3.42B
13.89%3.19B
19.41%3.24B
Receivable financing
-14.87%793.52M
-16.47%937.74M
-6.07%869.29M
105.49%1.35B
-4.04%932.12M
26.21%1.12B
28.11%925.41M
-2.21%657.03M
30.73%971.41M
8.10%889.55M
Other current assets
74.92%230.24M
96.22%229.84M
-34.69%184.38M
-45.36%182.07M
52.27%131.63M
7.10%117.13M
125.84%282.3M
170.07%333.22M
-21.87%86.45M
6.51%109.37M
Total current assets
1.42%20.49B
1.55%20.07B
7.69%20B
1.07%19.64B
8.39%20.2B
14.16%19.76B
1.27%18.57B
7.05%19.43B
5.14%18.64B
1.31%17.31B
Non Current assets
Other equity investment
-12.63%739.49M
-75.33%452.58M
-65.88%555.39M
-63.88%586.31M
-40.86%846.41M
74.56%1.83B
52.70%1.63B
52.34%1.62B
52.73%1.43B
13.26%1.05B
Long-term equity investment
4.01%1.11B
1.43%1.1B
2.27%1.11B
1.45%1.09B
-31.80%1.06B
-71.48%1.09B
-70.74%1.08B
-75.06%1.07B
-65.01%1.56B
-13.83%3.8B
Long term receivable account
-8.60%381.77M
-3.06%400.93M
-14.99%352.63M
-12.35%364.36M
-10.12%417.71M
-9.11%413.57M
-12.91%414.83M
-43.11%415.7M
-38.03%464.72M
-49.43%455.04M
Fixed assets
----
26.20%8.71B
----
----
----
24.65%6.91B
----
-6.38%5.27B
----
5.19%5.54B
Fixed assets liquidation
----
----
----
----
----
--2.81M
----
----
----
----
Constru in process
----
22.38%1.78B
----
----
----
-14.20%1.45B
----
131.85%2.74B
----
183.54%1.69B
Construction materials
----
-93.82%1.24M
----
----
----
255.12%20.05M
----
1,003.48%25.31M
----
78.86%5.65M
Intangible assets
18.60%2.03B
20.34%2.04B
6.72%2.05B
-1.81%1.91B
-15.82%1.71B
-9.30%1.7B
2.18%1.92B
11.75%1.95B
31.96%2.03B
22.28%1.87B
Development expenditure
-24.97%648.39M
-22.65%641.39M
-20.71%657.76M
-16.69%669M
8.60%864.14M
-15.74%829.17M
-12.66%829.52M
-11.57%802.99M
-5.70%795.74M
153.82%984.01M
Goodwill
-2.73%948.04M
-2.71%948.33M
-2.63%948.25M
-2.66%948.22M
-4.90%974.6M
-10.31%974.71M
-10.31%973.87M
-10.30%974.09M
5.41%1.02B
11.78%1.09B
Long deferred expense
-5.65%30.54M
4.83%32.02M
-4.23%32.31M
-6.43%34.62M
-13.71%32.36M
-23.41%30.55M
-15.30%33.74M
-14.89%37M
-9.31%37.5M
-7.71%39.88M
Deferred tax assets
14.10%79.99M
21.14%89.03M
30.55%89.23M
36.67%86.89M
24.58%70.1M
30.27%73.49M
5.33%68.35M
7.82%63.57M
-4.19%56.27M
-3.63%56.41M
Usufruct assets
-12.89%53.81M
-15.35%57.16M
-9.23%60.35M
-15.94%59.77M
-17.13%61.77M
-14.76%67.53M
-14.96%66.49M
-13.26%71.1M
-12.35%74.54M
-1.02%79.22M
Other non current assets
-80.94%351.01M
-85.70%252.52M
-74.00%407.76M
-74.68%393.59M
8.06%1.84B
4.65%1.77B
-10.12%1.57B
255.20%1.55B
415.10%1.7B
318.86%1.69B
Total non current assets
2.12%16.86B
-3.74%16.51B
-0.39%16.78B
-0.16%16.57B
-0.23%16.51B
-6.54%17.15B
-7.26%16.84B
-3.83%16.6B
2.39%16.55B
17.76%18.35B
Total assets
1.74%37.35B
-0.91%36.58B
3.85%36.78B
0.50%36.2B
4.34%36.71B
3.51%36.92B
-2.97%35.42B
1.74%36.02B
3.83%35.18B
9.16%35.66B
Liabilities
Current liabilities
Short term loan
-4.33%7.06B
1.97%7.06B
18.58%7.02B
1.88%6.71B
18.11%7.38B
-1.10%6.92B
-23.10%5.92B
-4.49%6.59B
-9.21%6.25B
3.57%7B
Transactional financial liabilities
----
----
----
----
----
--1.09M
--78.22K
--1.11M
----
----
Notes payable and accounts payable
-6.31%3.1B
-21.42%3.04B
-5.31%3.41B
-6.85%3.21B
12.52%3.31B
33.95%3.86B
33.55%3.61B
28.36%3.45B
9.12%2.94B
10.90%2.89B
-Notes payable
-53.44%256.76M
-71.48%233.6M
-55.64%378.17M
-22.06%495.24M
-7.59%551.46M
43.54%819.19M
55.18%852.44M
3.79%635.43M
-22.57%596.74M
-14.93%570.69M
-Accounts payable
3.10%2.85B
-7.95%2.8B
10.26%3.04B
-3.42%2.72B
17.64%2.76B
31.58%3.05B
28.03%2.75B
35.61%2.81B
21.80%2.35B
19.87%2.31B
Contract liabilities
-6.15%380M
-7.26%396.13M
-12.82%365.83M
-29.40%422.85M
7.55%404.88M
12.49%427.16M
5.29%419.63M
69.98%598.9M
22.54%376.46M
19.82%379.74M
Advance receipts
728.42%5.8M
-99.77%700.15K
-99.77%700.15K
-99.77%700.15K
-99.84%700.15K
-16.67%308.35M
-8.47%309.85M
-1.43%309.85M
260.86%427.27M
1,535.84%370.04M
Salaries payable
14.07%286.78M
177.34%321.51M
152.99%281.34M
37.37%395.26M
198.58%251.41M
52.78%115.93M
48.25%111.21M
196.42%287.73M
87.22%84.2M
58.50%75.88M
Taxs payable
13.54%388.06M
4.76%357.44M
14.36%323.56M
20.57%354.23M
-16.13%341.8M
-2.70%341.21M
-43.29%282.94M
-47.05%293.8M
11.06%407.53M
20.06%350.68M
Other payable (including interest and dividends)
-5.39%1.44B
-12.90%1.38B
-28.04%1.2B
-34.10%1.18B
-15.19%1.52B
-11.85%1.58B
1.41%1.67B
-4.30%1.79B
4.97%1.79B
11.27%1.8B
-Dividend payable
21.70%435.56M
-46.99%190.72M
222.44%249.17M
86.32%146.4M
31.37%357.9M
44.41%359.77M
1,672.49%77.28M
853.63%78.58M
68.63%272.44M
-24.77%249.14M
-Other payable
----
-2.88%1.19B
----
----
----
-20.91%1.22B
----
-8.10%1.71B
----
20.57%1.55B
Non current liabilities due within one year
27.29%1.02B
-42.50%798.14M
-34.74%849.46M
-48.54%903.27M
-66.83%803.1M
-35.25%1.39B
-49.97%1.3B
-35.72%1.76B
49.65%2.42B
56.42%2.14B
Other current liabilities
-5.70%41.92M
-20.42%40.78M
-17.29%40.05M
-35.11%44.01M
1.09%44.45M
12.22%51.25M
2.28%48.43M
36.21%67.82M
34.49%43.97M
9.03%45.67M
Total current liabilities
-2.37%13.73B
-10.76%13.39B
-1.26%13.5B
-12.66%13.23B
-4.66%14.06B
-0.29%15B
-14.59%13.68B
-2.65%15.14B
7.03%14.75B
15.14%15.05B
Current liabilities
Long term loan
-25.78%1.39B
0.52%1.71B
-4.28%1.71B
-10.14%1.67B
8.44%1.87B
-34.09%1.7B
-40.80%1.78B
-33.81%1.85B
-38.84%1.72B
-15.44%2.58B
Long term account payable
----
-63.12%41.08M
----
----
----
868.45%111.37M
----
-75.89%5M
----
-56.26%11.5M
Specific account payable
----
0.00%16M
----
----
----
-31.95%16M
----
-30.41%16.38M
----
-0.44%23.51M
Deferred tax liabilities
19.70%384.14M
-2.74%385.71M
-8.66%375.17M
-8.35%377.65M
24.11%320.92M
53.27%396.57M
58.02%410.76M
66.64%412.07M
16.07%258.58M
44.88%258.74M
Long term deferred income
9.37%736.41M
5.11%711.74M
15.13%688.34M
16.78%701.99M
14.60%673.31M
17.29%677.14M
3.94%597.88M
5.43%601.13M
2.10%587.52M
8.43%577.34M
Lease liabilities
-12.69%34.8M
-20.10%37.26M
-15.15%39.13M
-20.89%39.55M
-29.54%39.86M
-24.31%46.64M
-22.63%46.12M
-18.92%50M
-6.90%56.57M
1.53%61.62M
Total non current liabilities
-14.22%2.6B
-1.59%2.9B
-3.08%2.91B
-1.98%2.88B
13.94%3.03B
-16.09%2.95B
-24.11%3B
-30.02%2.94B
-44.96%2.66B
-29.01%3.52B
Total liabilities
-4.47%16.33B
-9.25%16.29B
-1.59%16.41B
-10.92%16.11B
-1.82%17.09B
-3.28%17.95B
-16.47%16.68B
-8.47%18.08B
-6.47%17.41B
3.01%18.56B
Shareholders equity
Paid-in capital
-0.02%1.63B
-0.02%1.63B
-0.02%1.63B
-0.02%1.63B
-0.03%1.63B
-0.03%1.63B
-0.02%1.63B
-0.02%1.63B
0.00%1.63B
0.00%1.63B
Capital reserve funds
-0.04%5.69B
-1.79%5.69B
-1.77%5.68B
-1.23%5.67B
-3.32%5.69B
-5.87%5.79B
-5.74%5.78B
-7.21%5.74B
-5.60%5.88B
-4.02%6.15B
Surplus reserve funds
23.73%489.53M
23.73%489.53M
23.73%489.53M
23.73%489.53M
0.00%395.65M
0.00%395.65M
0.00%395.65M
0.00%395.65M
0.00%395.65M
0.00%395.65M
Retained profit
9.54%9.95B
16.34%9.72B
23.73%9.84B
28.39%9.36B
29.24%9.08B
31.51%8.35B
32.43%7.96B
43.02%7.29B
39.21%7.03B
37.58%6.35B
Less:Treasury stock
-99.55%408.31K
-51.68%87.56M
-52.01%87.56M
-52.01%87.56M
-51.15%91.41M
-43.28%181.22M
-42.89%182.44M
-42.89%182.44M
-41.43%187.13M
-36.12%319.48M
Other composite income
259.94%109.48M
-167.96%-146.97M
-133.30%-53.01M
-113.94%-22.01M
-87.47%30.42M
709.62%216.26M
344.28%159.2M
428.84%157.85M
436.69%242.72M
133.41%26.71M
Shareholders equity without minority interests
6.74%17.87B
6.70%17.29B
11.19%17.5B
13.34%17.04B
11.63%16.74B
13.82%16.2B
14.19%15.74B
16.13%15.04B
16.08%15B
14.14%14.24B
Minority interests
9.47%3.15B
8.71%3B
-4.43%2.87B
5.15%3.06B
3.54%2.88B
-3.73%2.76B
8.97%3B
7.46%2.91B
17.94%2.78B
31.47%2.86B
Total shareholder equity
7.14%21.02B
6.99%20.29B
8.69%20.37B
12.02%20.1B
10.36%19.62B
10.88%18.96B
13.33%18.74B
14.63%17.94B
16.37%17.78B
16.72%17.1B
Total liabilityies and equity
1.74%37.35B
-0.91%36.58B
3.85%36.78B
0.50%36.2B
4.34%36.71B
3.51%36.92B
-2.97%35.42B
1.74%36.02B
3.83%35.18B
9.16%35.66B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -15.92%3.84B-12.90%3.55B9.53%3.54B-20.70%4.1B13.36%4.57B30.42%4.08B-9.23%3.23B0.21%5.18B-9.25%4.03B-24.29%3.13B
Transactional financial assets 1.83%918.86M2.14%926.84M1.41%925.16M-1.04%935.93M-4.65%902.31M-3.26%907.39M-1.01%912.32M1.21%945.72M72.56%946.3M71.08%938.01M
Notes receivable and accounts receivable 9.37%9.82B6.93%9.46B9.12%9.38B7.78%8.21B9.25%8.98B13.29%8.85B14.01%8.6B11.75%7.62B11.44%8.22B11.37%7.81B
-Notes receivable 46.93%80.44M8.13%89.34M-4.91%75.91M7.41%96.08M39.82%54.75M72.85%82.63M33.14%79.83M51.39%89.44M12.08%39.15M14.82%47.8M
-Accounts receivable 9.13%9.74B6.91%9.37B9.26%9.31B7.79%8.11B9.10%8.93B12.93%8.77B13.86%8.52B11.41%7.53B11.43%8.18B11.35%7.76B
Other receivables (including interest and dividends) -21.68%405.47M-15.55%454.22M-1.50%502.83M18.82%503.2M-2.52%517.73M3.55%537.86M-67.58%510.5M-29.30%423.51M-49.75%531.12M-50.84%519.44M
-Dividend receivable ------------------29.44M-----------------46.32%12.56M
-Accrued interest receivable ------------------8.83M--------------------
-Other receivable -----15.55%454.22M----------479.47M6.11%537.86M-----26.09%423.51M-----50.94%506.88M
Advance payment -27.86%545.48M-18.43%618.39M-0.01%786.33M-14.38%721.24M17.09%756.16M13.21%758.11M11.57%786.38M18.27%842.41M0.14%645.81M-4.31%669.67M
Inventories 15.49%3.92B14.76%3.88B14.59%3.81B5.80%3.62B6.43%3.4B4.36%3.38B4.16%3.32B9.40%3.42B13.89%3.19B19.41%3.24B
Receivable financing -14.87%793.52M-16.47%937.74M-6.07%869.29M105.49%1.35B-4.04%932.12M26.21%1.12B28.11%925.41M-2.21%657.03M30.73%971.41M8.10%889.55M
Other current assets 74.92%230.24M96.22%229.84M-34.69%184.38M-45.36%182.07M52.27%131.63M7.10%117.13M125.84%282.3M170.07%333.22M-21.87%86.45M6.51%109.37M
Total current assets 1.42%20.49B1.55%20.07B7.69%20B1.07%19.64B8.39%20.2B14.16%19.76B1.27%18.57B7.05%19.43B5.14%18.64B1.31%17.31B
Non Current assets
Other equity investment -12.63%739.49M-75.33%452.58M-65.88%555.39M-63.88%586.31M-40.86%846.41M74.56%1.83B52.70%1.63B52.34%1.62B52.73%1.43B13.26%1.05B
Long-term equity investment 4.01%1.11B1.43%1.1B2.27%1.11B1.45%1.09B-31.80%1.06B-71.48%1.09B-70.74%1.08B-75.06%1.07B-65.01%1.56B-13.83%3.8B
Long term receivable account -8.60%381.77M-3.06%400.93M-14.99%352.63M-12.35%364.36M-10.12%417.71M-9.11%413.57M-12.91%414.83M-43.11%415.7M-38.03%464.72M-49.43%455.04M
Fixed assets ----26.20%8.71B------------24.65%6.91B-----6.38%5.27B----5.19%5.54B
Fixed assets liquidation ----------------------2.81M----------------
Constru in process ----22.38%1.78B-------------14.20%1.45B----131.85%2.74B----183.54%1.69B
Construction materials -----93.82%1.24M------------255.12%20.05M----1,003.48%25.31M----78.86%5.65M
Intangible assets 18.60%2.03B20.34%2.04B6.72%2.05B-1.81%1.91B-15.82%1.71B-9.30%1.7B2.18%1.92B11.75%1.95B31.96%2.03B22.28%1.87B
Development expenditure -24.97%648.39M-22.65%641.39M-20.71%657.76M-16.69%669M8.60%864.14M-15.74%829.17M-12.66%829.52M-11.57%802.99M-5.70%795.74M153.82%984.01M
Goodwill -2.73%948.04M-2.71%948.33M-2.63%948.25M-2.66%948.22M-4.90%974.6M-10.31%974.71M-10.31%973.87M-10.30%974.09M5.41%1.02B11.78%1.09B
Long deferred expense -5.65%30.54M4.83%32.02M-4.23%32.31M-6.43%34.62M-13.71%32.36M-23.41%30.55M-15.30%33.74M-14.89%37M-9.31%37.5M-7.71%39.88M
Deferred tax assets 14.10%79.99M21.14%89.03M30.55%89.23M36.67%86.89M24.58%70.1M30.27%73.49M5.33%68.35M7.82%63.57M-4.19%56.27M-3.63%56.41M
Usufruct assets -12.89%53.81M-15.35%57.16M-9.23%60.35M-15.94%59.77M-17.13%61.77M-14.76%67.53M-14.96%66.49M-13.26%71.1M-12.35%74.54M-1.02%79.22M
Other non current assets -80.94%351.01M-85.70%252.52M-74.00%407.76M-74.68%393.59M8.06%1.84B4.65%1.77B-10.12%1.57B255.20%1.55B415.10%1.7B318.86%1.69B
Total non current assets 2.12%16.86B-3.74%16.51B-0.39%16.78B-0.16%16.57B-0.23%16.51B-6.54%17.15B-7.26%16.84B-3.83%16.6B2.39%16.55B17.76%18.35B
Total assets 1.74%37.35B-0.91%36.58B3.85%36.78B0.50%36.2B4.34%36.71B3.51%36.92B-2.97%35.42B1.74%36.02B3.83%35.18B9.16%35.66B
Liabilities
Current liabilities
Short term loan -4.33%7.06B1.97%7.06B18.58%7.02B1.88%6.71B18.11%7.38B-1.10%6.92B-23.10%5.92B-4.49%6.59B-9.21%6.25B3.57%7B
Transactional financial liabilities ----------------------1.09M--78.22K--1.11M--------
Notes payable and accounts payable -6.31%3.1B-21.42%3.04B-5.31%3.41B-6.85%3.21B12.52%3.31B33.95%3.86B33.55%3.61B28.36%3.45B9.12%2.94B10.90%2.89B
-Notes payable -53.44%256.76M-71.48%233.6M-55.64%378.17M-22.06%495.24M-7.59%551.46M43.54%819.19M55.18%852.44M3.79%635.43M-22.57%596.74M-14.93%570.69M
-Accounts payable 3.10%2.85B-7.95%2.8B10.26%3.04B-3.42%2.72B17.64%2.76B31.58%3.05B28.03%2.75B35.61%2.81B21.80%2.35B19.87%2.31B
Contract liabilities -6.15%380M-7.26%396.13M-12.82%365.83M-29.40%422.85M7.55%404.88M12.49%427.16M5.29%419.63M69.98%598.9M22.54%376.46M19.82%379.74M
Advance receipts 728.42%5.8M-99.77%700.15K-99.77%700.15K-99.77%700.15K-99.84%700.15K-16.67%308.35M-8.47%309.85M-1.43%309.85M260.86%427.27M1,535.84%370.04M
Salaries payable 14.07%286.78M177.34%321.51M152.99%281.34M37.37%395.26M198.58%251.41M52.78%115.93M48.25%111.21M196.42%287.73M87.22%84.2M58.50%75.88M
Taxs payable 13.54%388.06M4.76%357.44M14.36%323.56M20.57%354.23M-16.13%341.8M-2.70%341.21M-43.29%282.94M-47.05%293.8M11.06%407.53M20.06%350.68M
Other payable (including interest and dividends) -5.39%1.44B-12.90%1.38B-28.04%1.2B-34.10%1.18B-15.19%1.52B-11.85%1.58B1.41%1.67B-4.30%1.79B4.97%1.79B11.27%1.8B
-Dividend payable 21.70%435.56M-46.99%190.72M222.44%249.17M86.32%146.4M31.37%357.9M44.41%359.77M1,672.49%77.28M853.63%78.58M68.63%272.44M-24.77%249.14M
-Other payable -----2.88%1.19B-------------20.91%1.22B-----8.10%1.71B----20.57%1.55B
Non current liabilities due within one year 27.29%1.02B-42.50%798.14M-34.74%849.46M-48.54%903.27M-66.83%803.1M-35.25%1.39B-49.97%1.3B-35.72%1.76B49.65%2.42B56.42%2.14B
Other current liabilities -5.70%41.92M-20.42%40.78M-17.29%40.05M-35.11%44.01M1.09%44.45M12.22%51.25M2.28%48.43M36.21%67.82M34.49%43.97M9.03%45.67M
Total current liabilities -2.37%13.73B-10.76%13.39B-1.26%13.5B-12.66%13.23B-4.66%14.06B-0.29%15B-14.59%13.68B-2.65%15.14B7.03%14.75B15.14%15.05B
Current liabilities
Long term loan -25.78%1.39B0.52%1.71B-4.28%1.71B-10.14%1.67B8.44%1.87B-34.09%1.7B-40.80%1.78B-33.81%1.85B-38.84%1.72B-15.44%2.58B
Long term account payable -----63.12%41.08M------------868.45%111.37M-----75.89%5M-----56.26%11.5M
Specific account payable ----0.00%16M-------------31.95%16M-----30.41%16.38M-----0.44%23.51M
Deferred tax liabilities 19.70%384.14M-2.74%385.71M-8.66%375.17M-8.35%377.65M24.11%320.92M53.27%396.57M58.02%410.76M66.64%412.07M16.07%258.58M44.88%258.74M
Long term deferred income 9.37%736.41M5.11%711.74M15.13%688.34M16.78%701.99M14.60%673.31M17.29%677.14M3.94%597.88M5.43%601.13M2.10%587.52M8.43%577.34M
Lease liabilities -12.69%34.8M-20.10%37.26M-15.15%39.13M-20.89%39.55M-29.54%39.86M-24.31%46.64M-22.63%46.12M-18.92%50M-6.90%56.57M1.53%61.62M
Total non current liabilities -14.22%2.6B-1.59%2.9B-3.08%2.91B-1.98%2.88B13.94%3.03B-16.09%2.95B-24.11%3B-30.02%2.94B-44.96%2.66B-29.01%3.52B
Total liabilities -4.47%16.33B-9.25%16.29B-1.59%16.41B-10.92%16.11B-1.82%17.09B-3.28%17.95B-16.47%16.68B-8.47%18.08B-6.47%17.41B3.01%18.56B
Shareholders equity
Paid-in capital -0.02%1.63B-0.02%1.63B-0.02%1.63B-0.02%1.63B-0.03%1.63B-0.03%1.63B-0.02%1.63B-0.02%1.63B0.00%1.63B0.00%1.63B
Capital reserve funds -0.04%5.69B-1.79%5.69B-1.77%5.68B-1.23%5.67B-3.32%5.69B-5.87%5.79B-5.74%5.78B-7.21%5.74B-5.60%5.88B-4.02%6.15B
Surplus reserve funds 23.73%489.53M23.73%489.53M23.73%489.53M23.73%489.53M0.00%395.65M0.00%395.65M0.00%395.65M0.00%395.65M0.00%395.65M0.00%395.65M
Retained profit 9.54%9.95B16.34%9.72B23.73%9.84B28.39%9.36B29.24%9.08B31.51%8.35B32.43%7.96B43.02%7.29B39.21%7.03B37.58%6.35B
Less:Treasury stock -99.55%408.31K-51.68%87.56M-52.01%87.56M-52.01%87.56M-51.15%91.41M-43.28%181.22M-42.89%182.44M-42.89%182.44M-41.43%187.13M-36.12%319.48M
Other composite income 259.94%109.48M-167.96%-146.97M-133.30%-53.01M-113.94%-22.01M-87.47%30.42M709.62%216.26M344.28%159.2M428.84%157.85M436.69%242.72M133.41%26.71M
Shareholders equity without minority interests 6.74%17.87B6.70%17.29B11.19%17.5B13.34%17.04B11.63%16.74B13.82%16.2B14.19%15.74B16.13%15.04B16.08%15B14.14%14.24B
Minority interests 9.47%3.15B8.71%3B-4.43%2.87B5.15%3.06B3.54%2.88B-3.73%2.76B8.97%3B7.46%2.91B17.94%2.78B31.47%2.86B
Total shareholder equity 7.14%21.02B6.99%20.29B8.69%20.37B12.02%20.1B10.36%19.62B10.88%18.96B13.33%18.74B14.63%17.94B16.37%17.78B16.72%17.1B
Total liabilityies and equity 1.74%37.35B-0.91%36.58B3.85%36.78B0.50%36.2B4.34%36.71B3.51%36.92B-2.97%35.42B1.74%36.02B3.83%35.18B9.16%35.66B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme The Concept of in Vitro Diagnosis
The Concept of in Vitro Diagnosis
Intraday+0.64%
Biological Vaccine
Biological Vaccine
Intraday+0.60%
Virus Prevention
Virus Prevention
Intraday+0.51%